These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial. Tonneijck L; Smits MM; Muskiet MHA; Hoekstra T; Kramer MHH; Danser AHJ; Diamant M; Joles JA; van Raalte DH Diabetologia; 2016 Jul; 59(7):1412-1421. PubMed ID: 27038451 [TBL] [Abstract][Full Text] [Related]
5. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension. Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876 [TBL] [Abstract][Full Text] [Related]
6. Renal perfusion evaluation with contrast-enhanced ultrasonography. Schneider AG; Hofmann L; Wuerzner G; Glatz N; Maillard M; Meuwly JY; Eggimann P; Burnier M; Vogt B Nephrol Dial Transplant; 2012 Feb; 27(2):674-81. PubMed ID: 21690200 [TBL] [Abstract][Full Text] [Related]
7. Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Schmidt BM; Sammer U; Fleischmann I; Schlaich M; Delles C; Schmieder RE Hypertension; 2006 Apr; 47(4):650-5. PubMed ID: 16520409 [TBL] [Abstract][Full Text] [Related]
8. Effect of N Högstedt A; Iredahl F; Tesselaar E; Farnebo S Microcirculation; 2020 Apr; 27(3):e12597. PubMed ID: 31628700 [TBL] [Abstract][Full Text] [Related]
9. Assessment of endothelial function of the renal vasculature in human subjects. Delles C; Jacobi J; Schlaich MP; John S; Schmieder RE Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856 [TBL] [Abstract][Full Text] [Related]
10. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Bech JN; Nielsen CB; Ivarsen P; Jensen KT; Pedersen EB Am J Physiol; 1998 May; 274(5):F914-23. PubMed ID: 9612329 [TBL] [Abstract][Full Text] [Related]
11. Perfusion pressure and volume status determine the microvascular response of the rat kidney to NG-monomethyl-L-arginine. Lockhart JC; Larson TS; Knox FG Circ Res; 1994 Nov; 75(5):829-35. PubMed ID: 7923628 [TBL] [Abstract][Full Text] [Related]
12. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Millar CG; Thiemermann C Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724 [TBL] [Abstract][Full Text] [Related]
14. Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials. Tonneijck L; Muskiet MHA; Smits MM; Bjornstad P; Kramer MHH; Diamant M; Hoorn EJ; Joles JA; van Raalte DH Diabetes Obes Metab; 2018 May; 20(5):1235-1245. PubMed ID: 29341461 [TBL] [Abstract][Full Text] [Related]
15. Renal effects of NO-inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo-controlled crossover study. Bech JN; Aagaard NK; Pedersen RS; Sorensen TB; Vilstrup H; Pedersen EB Liver Int; 2014 Feb; 34(2):211-9. PubMed ID: 23809512 [TBL] [Abstract][Full Text] [Related]
16. Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes. Aung MM; Slade K; Freeman LAR; Kos K; Whatmore JL; Shore AC; Gooding KM Diabetologia; 2019 Sep; 62(9):1701-1711. PubMed ID: 31203378 [TBL] [Abstract][Full Text] [Related]
17. A dose-response study of nitric oxide synthase inhibition in different vascular beds in man. Hjorth Lassen L; Klingenberg Iversen H; Olesen J Eur J Clin Pharmacol; 2003 Oct; 59(7):499-505. PubMed ID: 13680036 [TBL] [Abstract][Full Text] [Related]
18. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men. Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis. La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729 [TBL] [Abstract][Full Text] [Related]
20. Renal resistive index--a valid tool to assess renal endothelial function in humans? Raff U; Schwarz TK; Schmidt BM; Schneider MP; Schmieder RE Nephrol Dial Transplant; 2010 Jun; 25(6):1869-74. PubMed ID: 20142629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]